Flerie AB (publ) (FRA:1NP1)

Market Cap	118.54M -58.4%
Revenue (ttm)	229.36K +4.0%
Net Income	-86.04M
EPS	-0.93
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,015
Open	1.240
Previous Close	1.220
Day's Range	1.240 - 1.240
52-Week Range	1.210 - 3.181
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 15, 2026

About Flerie AB

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Employees: 8
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1NP1

Financial Performance

In 2025, Flerie AB's revenue was 2.50 million, a decrease of -3.85% compared to the previous year's 2.60 million. Losses were -756.90 million, 232.0% more than in 2024.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error